Exscientia stock.

Dec 1, 2023 · The Exscientia plc stock price gained 1.15% on the last trading day (Friday, 1st Dec 2023), rising from $6.10 to $6.17. During the last trading day the stock fluctuated 5.73% from a day low at $5.93 to a day high of $6.27. The price has been going up and down for this period, and there has been a 3.35% gain for the last 2 weeks.

Exscientia stock. Things To Know About Exscientia stock.

Exscientia Plc engages in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of therapeutic compounds. The company was founded by Andrew L. Hopkins in 2012 and is headquartered in Oxford, the United Kingdom.Exscientia plc (Nasdaq: EXAI) will report financial results for the third quarter ended September 30, 2023, on Thursday, November 9, 2023, before the open of U.S. markets. The Company will host a conference call and webcast at 1:30 p.m. GMT / 8:30 a.m. EST to provide a business update and review financial results.This came just a few months after Recursion raised $436 million in an upsized IPO in April 2021 (Table 1). Exscientia, a pioneer in applying AI to small-molecule drug design, had a hefty IPO in ...1 июл. 2023 г. ... ... Exscientia, and Abcellera. As for Schrodinger, that's not an AI stock, but the only one of the lot we're holding in our own tech stock ...

Exscientia stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Exscientia analysts is $ 9.5 . Today 200 Day Moving Average is the resistance level ( 6.25 $).

Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently up 22.35% so far this month. During the month of October, Exscientia PLC (ADR)’s stock price has reached a high of $6.02 and a low of $4.17. Over the last year, Exscientia PLC (ADR) has hit prices as high as $11.52 and as low as $4.09. Year to date ...

May 18, 2023 · Exscientia's AI-driven drug discovery platform positioned the company at the forefront of precision medicine. Read why EXAI stock is a Buy. Dec 1, 2023 · According to 3 stock analysts, the average 12-month stock price forecast for Exscientia stock is $10, which predicts an increase of 62.07%. The lowest target is $7.00 and the highest is $13. On average, analysts rate Exscientia stock as a buy. Exscientia plc (Nasdaq: EXAI) today announced that members of Exscientia management will participate in a fireside chat at the 6 th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023, at 3:25 p.m. EST (8:25 p.m. GMT).. A live webcast of the fireside chat will be available on the Company’s website, …25 окт. 2023 г. ... Overall market sentiment has been high on Exscientia PLC (EXAI) stock lately. EXAI receives a Bullish rating from InvestorsObserver Stock ...

That was the dynamic behind artificial intelligence (AI)-powered healthcare-solutions provider Exscientia 's ( EXAI 1.15%) more than 6% leap in share price on Wednesday. That made the stock quite ...

Mar 14, 2023 · OXFORD, England, March 14, 2023--Exscientia plc (Nasdaq: EXAI) today announced two new wholly-owned precision oncology development candidates, EXS74539 (‘539), an LSD1 inhibitor, and EXS73565 ...

Within 3 weeks, Exscientia, a 2012 spinoff of the University of Dundee, UK, announced a $225 million Series D financing round (Table 1), along with a $300 million equity commitment that it can ...Exscientia Plc has an analyst consensus of Moderate Buy, with a price target consensus of $14.00. See the top stocks recommended by analysts >> EXAI market cap is currently $883.3M and has a P/E ...The Exscientia plc stock price gained 2.18% on the last trading day (Friday, 17th Nov 2023), rising from $5.97 to $6.10. During the last trading day the stock fluctuated 7.85% from a day low at $5.86 to a day high of $6.32. The price has been going up and down for this period, and there has been a 4.99% gain for the last 2 weeks.Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently up 7.65% so far this month. During the month of June, Exscientia PLC (ADR)’s stock price has reached a high of $8.39 and a low of $6.70. Over the last year, Exscientia PLC (ADR) has hit prices as high as $16.45 and as low as $4.09. Year to date, Exscientia ...Exscientia is a clinical-stage precision medicine company that uses AI to develop oncology therapies. The stock is up more than 6% this year. In the second quarter, the company made several ...Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Track Exscientia Ltd - ADR (EXAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Company profile page for Exscientia Plc including stock price, company news, executives, board members, and contact informationShares of Exscientia PLC Sponsored ADR (EXAI) have gained 7.6% over the past four weeks to close the last trading session at $5.40, but there could still be a solid upside left in the stock if ...Date Filing Type Filing Description Download / View. November 9, 2023. 6-K. Report of Foreign Issuer. September 20, 2023. 6-K. Report of Foreign Issuer. August 10, 2023. 6-K.EXAI: Exscientia Plc Stock Price Quote - NASDAQ GS - Bloomberg Bloomberg Connecting decision makers to a dynamic network of information, people and …Exscientia PLC Sponsored ADR EXAI shares soared 13.5% in the last trading session to close at $5.29. The move was backed by solid volume with far more shares changing hands than in a normal session.25 окт. 2023 г. ... Overall market sentiment has been high on Exscientia PLC (EXAI) stock lately. EXAI receives a Bullish rating from InvestorsObserver Stock ...

Oxford-based Exscientia is a clinical-stage pharmatech that uses Artificial Intelligence (AI) to design and discover new drugs. The company just announced that BlackRock’s funds joined its Series C investment round, closing the round at $100 million (nearly £72 million). ... Robinhood to launch stock trading services in UK after failed ...

Nov 7, 2023 · Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently up 7.04% so far this month. During the month of November, Exscientia PLC (ADR)’s stock price has reached a high of $6.10 and a low of $5.15. Over the last year, Exscientia PLC (ADR) has hit prices as high as $11.52 and as low as $4.09. Year to date ... In light of these risks and uncertainties, and other risks and uncertainties that are described in the Risk Factors section and other sections of Exscientia’s Annual Report on Form 20-F, filed with the Securities and Exchange Commission (SEC) on March 23, 2022 (File No. 001-40850), and other filings that Exscientia makes with the SEC from ...Exscientia is a clinical-stage precision medicine company that uses AI to develop oncology therapies. The stock is up more than 6% this year. In the second quarter, the company made several ...Shares of Exscientia (EXAI 2.18%) ... The stock is up more than 38% so far this year. So what. Exscienta is an AI-driven precision medicine company that focuses on oncology therapies. The clinical ...Oct 1, 2021 · Exscientia’s market value soared as shares of the artificial intelligence (AI) p harmaceutical-technology (pharmatech) company debuted on the stock market. Shares of the Oxford, England company rose more than 30% following Exscientia’s upsized initial public offering (IPO). About Exscientia Stock Founded 10 years ago, Exscientia describes itself as a pharmatech company with an end-to-end AI-powered platform that leverages experimental technologies for identifying potential disease targets and then designing drugs that would be the most effective and safe.

That was the dynamic behind artificial intelligence (AI)-powered healthcare-solutions provider Exscientia 's ( EXAI 1.15%) more than 6% leap in share price on Wednesday. That made the stock quite ...

Sep 20, 2023 · Exscientia will receive an upfront payment of $20 million in cash and be eligible for milestone payments of up to $674 million in total. If a drug is commercialized, the company will also receive ...

Exscientia PLC (ADR) Stock Price History. Exscientia PLC (ADR)’s price is currently down 14.9% so far this month. During the month of March, Exscientia PLC (ADR)’s stock price has reached a high of $7.11 and a low of $5.50. Over the last year, Exscientia PLC (ADR) has hit prices as high as $16.45 and as low as $4.09. Year to date ...Green's #1 AI Stock Summary. Creator: Alexander Green. Newsletter: Oxford Communique. Stock: Exscientia (EXIA) The stock that is being hyped up by Alexander Green is Exscientia. Exscientia is a company specializing in leveraging artificial intelligence for drug discovery, with a focus on designing and developing small-molecule drugs.Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...Legal Name Exscientia Ltd. Stock Symbol NASDAQ:EXAI. Company Type For Profit. Contact Email [email protected]. Phone Number +44-1865-818941. Exscientia …Overview | EXAI U.S.: Nasdaq Exscientia PLC ADR Watch NEW Set a price target alert Premarket Last Updated: Nov 30, 2023 5:47 a.m. EST Delayed quote $ 6.01 0.01 0.17% Before Hours Volume: 87...Exscientia Plc engages in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of therapeutic compounds. The company was founded by Andrew L. Hopkins in 2012 and is headquartered in Oxford, the United Kingdom.Find the latest Hon Hai Precision Industry Co., Ltd. (HNHPF) stock quote, history, news and other vital information to help you with your stock trading and investing.EXAI: Exscientia Plc Stock Price Quote - NASDAQ GS - Bloomberg Bloomberg Connecting decision makers to a dynamic network of information, people and …Revenue: Revenue for the three and nine months ended September 30, 2023 was $10.8 million and $21.6 million respectively, compared to $7.7 million and $24.9 million for the three and nine months ...

OXFORD, England-- (BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) announced today that it is expanding its technology management structure to accelerate application of Exscientia's innovative technologies to catalyse instrumental change in the way drug candidates are being discovered, designed and developed for patients in need …Exscientia will be reporting Q4 earnings on March 23. Wall Street predict expect Exscientia will report losses per share of $0.370; Go here to track Exscientia stock price in real-time on Markets ...Shares of Exscientia (EXAI 2.18%) ... The stock is up more than 38% so far this year. So what. Exscienta is an AI-driven precision medicine company that focuses on oncology therapies. The clinical ...Find real-time EXAI - Exscientia PLC stock quotes, company profile, news and forecasts from CNN Business.Instagram:https://instagram. otcmkts remrfcombatesvtsaaxdell quarterly results Exscientia Plc American Depositary Shares (EXAI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Like Recursion, Exscientia (NYSE: EXAI) uses AI in its approach to drug discovery.Unlike Recusion, Exscientia aims to develop bespoke drug solutions for patients. Exscientia was the first to bring ... usrt dividendwhy is albemarle stock dropping Get the latest Exscientia plc (EXAI) stock quote, history, news and other vital information to help you with your stock trading and investing. See the current price, performance outlook, earnings date, dividend yield, research reports and more for EXAI on NasdaqGS. pbt stock price Nov 24, 2023 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Exscientia stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for EXAI. The average twelve-month price prediction for Exscientia is $10.25 with a high price target of $13.00 and a low price target of $7.00. EXS73565. MALT1. * Phase 3 may not be required if Phase 2 is registrational: PKC-theta is in a Phase 1 healthy volunteer study. Does not include Sumitomo Pharma programmes. Our pipeline demonstrates our ability to rapidly translate scientific concepts and patient-centric data into precision-designed therapeutic candidates.